Binary classification task performance. by Thierry Jean (20691795)

Subjects:

Time-based splitting strategy and forecast horizons. by Thierry Jean (20691795)

Subjects:

Label distributions across mental states and dataset splits. by Thierry Jean (20691795)

Subjects:

Effect of class imbalance on predictive performance. by Thierry Jean (20691795)

Subjects:

Ordinal regression predictions. by Thierry Jean (20691795)

Subjects:

Binary classification predictions. by Thierry Jean (20691795)

Subjects:

Ordinal regression task performance. by Thierry Jean (20691795)

Subjects:

Surveys. by Thierry Jean (20691795)

Subjects:

Increased <i>Huwe1</i> after induction of Sox2 in mouse ES cells. by Yen-Fu Cheng (5819855)

“…<i>Atoh1</i> expression increased with <i>Sox2</i> at low levels but decreased at higher <i>Sox2</i> level. …”

The biochemical data and protein expression levels. by Liping Bao (2936715)

COVID19 effect on essential services. by Admas Abera (11821659)

“…The present study found that the mean number of patients treated for TB declined by 35 patients (β: -34.62; 95%CI: -50.29, -18.95) compared to the pre-COVID-19 era while the number of new patients enrolled for ART decreased by 71 patients (β: -70.62; 95%CI: -107.19, -34.05). …”

I.p. injection of LPS induces inflammation in the brain A. by Fionä Caratis (12759506)

Subjects:

Tight junction and adhesion proteins in the brain are downregulated during systemic inflammation. by Fionä Caratis (12759506)

Subjects:

Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

Subjects:

Median EQ-5D-3L index values during 5 years of follow-up. by Karl Ingard (22582091)

Subjects:

Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

Subjects:

Subgroup Analysis of the Occurrence of Secondary Endpoints. by Karl Ingard (22582091)

Subjects:

Study flow chart. by Karl Ingard (22582091)

Subjects:

Kaplan-Meier curve of the primary outcome. by Karl Ingard (22582091)

Subjects:

Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. by Karl Ingard (22582091)

Subjects: